What the company does
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
What the weekly tape is saying
JNJ closed the latest completed week at 240.9 USD. The 4-week return is 6.9% and the 12-week return is 2.9%. Trend Signal is active, Market Dynamics is -0.79. Setup signature: Balanced read with a 70/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 224.9 USD
- Vs Trend Line
- 7.1%
- Fair Value
- 166.0 USD
- Vs Fair Value
- 45.1%
- 52W High
- 250.3 USD
- 52W Low
- 145.4 USD
- Drawdown
- -3.7%
- Range Position
- 91.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 63 weeks
- 52W Active Weeks
- 52
- 52W Active Breadth
- 100.0%
- Sector Scope
- US Healthcare
- Sector Rank
- 322 of 1038
- Sector Percentile
- 69.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- 32 of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Drug Manufacturers - General
- Tracked Peers
- 20
- 4W Rank
- 7 of 20
- Avg 1W
- 1.4%
- Avg 4W
- 5.4%
- Trend Breadth
- 35.0%
- Positive RS
- 40.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.79
- 4W MD Change
- 25.7%
- Relative Strength
- 7.94
- 4W RS Change
- 184.9%
- Expectation
- Undecided
- Probability
- 50.00%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 38.1M
- 13W Average
- 37.2M
- 52W Average
- 40.6M
- Vs 13W
- 1.0x
- Vs 52W
- 0.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.6%
- 52W Volatility
- 2.6%
- Upside Weeks
- 31
- Downside Weeks
- 21
- Downside Breadth
- 40.4%
- Avg Gain / Loss
- 2.7% / -1.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NYSE
- Country
- US
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
- Market Cap
- 556.8B
Opportunity signals
- Trend Signal is active with a 63-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 240.9 USD | 3.5% | 224.9 USD | 166.0 USD | -0.79 | 7.94 | 38.1M | On |
| 5 Jun 2026 | 232.8 USD | 3.3% | 223.3 USD | 165.4 USD | -0.97 | 5.34 | 35.5M | On |
| 29 May 2026 | 225.3 USD | -3.3% | 221.7 USD | 164.9 USD | -1.06 | -0.19 | 33.6M | On |
| 22 May 2026 | 233.0 USD | 3.4% | 220.3 USD | 164.4 USD | -1.05 | 4.96 | 37.1M | On |
| 15 May 2026 | 225.4 USD | 2.4% | 218.8 USD | 163.8 USD | -1.06 | 2.79 | 41.5M | On |
| 8 May 2026 | 220.0 USD | -2.6% | 217.6 USD | 163.3 USD | -0.97 | 0.92 | 34.6M | On |
| 1 May 2026 | 225.9 USD | -0.1% | 216.5 USD | 162.8 USD | -0.74 | 6.25 | 37.2M | On |
| 24 Apr 2026 | 226.2 USD | -2.9% | 215.2 USD | 162.3 USD | -0.40 | 7.70 | 41.7M | On |
| 17 Apr 2026 | 232.8 USD | -1.8% | 213.5 USD | 161.8 USD | -0.03 | 11.77 | 42.1M | On |
| 10 Apr 2026 | 237.1 USD | -1.9% | 211.5 USD | 161.3 USD | 0.25 | 19.22 | 33.0M | On |
| 2 Apr 2026 | 241.6 USD | 1.1% | 209.5 USD | 160.7 USD | 0.60 | 26.48 | 28.0M | On |
| 27 Mar 2026 | 239.1 USD | 2.2% | 207.3 USD | 160.1 USD | 0.81 | 30.04 | 35.6M | On |
| 20 Mar 2026 | 234.0 USD | -2.5% | 205.1 USD | 159.5 USD | 1.06 | 25.18 | 46.3M | On |
| 13 Mar 2026 | 240.1 USD | 0.5% | 203.1 USD | 158.9 USD | 1.27 | 26.79 | 36.1M | On |